Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose

Drug Safety(2023)10.1007/s40264-023-01281-9Source: DataRank Database

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose is a research paper published in Drug Safety (2023). On theSindex it has a DataRank of 0.500. It has been cited 27 times.

N/A

0.500DataRank · unranked

Scored on demand from live citation data

27 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.56)OA: bronzeTopics (29)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.500

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (16)

Florence van Hunsel ORCID,Nicolas H. Thurin ORCID,Caroline Dureau-Pournin ORCID,Dirk Mentzer,Barbara Kovačić

Live enrichment

PubMed:37024736 PMC:PMC10079486 OpenAlex:https://openalex.org/W4362692207

European Medicines Agency

Grant: EMA/2018/28/PE

Ministerie van Volksgezondheid, Welzijn en Sport

Paul-Ehrlich-Institut

Ministère de la Santé et des Solidarités and the Ministère de l’Enseignement supérieur, de la Recherche et de l’Innovation

the Agency for Medicinal Products and Medical Devices of Croatia

FWCI

4.56

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: https://www.springernature.com/gp/researchers/text-and-data-mining

journalhttps://link.springer.com/content/pdf/10.1007/s40264-023-01281-9.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s40264-023-01281-9.pdf

publisherhttps://link.springer.com/article/10.1007/s40264-023-01281-9/fulltext.html

journalhttps://doi.org/10.1007/s40264-023-01281-9

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37024736

Fields of Study

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug ReactionsVaccine Coverage and Hesitancy

MeSH Terms

COVID-19COVID-19 VaccinesAdultAgedBelgiumEuropeFemaleHumansMaleMiddle AgedProspective Studies

Keywords

MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Adverse effectCohortCohort studyVirologyEnvironmental healthIntensive care medicineEmergency medicineInternal medicineOutbreakInfectious disease (medical specialty)Disease

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose

FAIR Checklist

DataRank Breakdown

Authors (16)

Funding (5 grants)

Impact

Open Access

Topics